Clinical outcomes of endoscopic submucosal dissection for giant rectal tumors larger than 8 cm: A European referral center experience

Dig Liver Dis. 2023 Oct;55(10):1391-1396. doi: 10.1016/j.dld.2023.05.032. Epub 2023 Jun 12.

Abstract

Background and aims: To date, western data on colorectal ESD are limited. This study aimed to assess the efficacy and safety of rectal ESD for superficial lesions ≥ 8 cm.

Methods: A total of 138 superficial rectal neoplasms treated by ESD were allocated in two groups: 25 in the "giant" ESD group and 113 in the control group.

Results: En bloc resection was achieved in 96% of cases in both groups. En bloc R0 resection rate was similar between the "giant" ESD group and the control group (84% vs 86%; p: 0.5) and curative resection was higher in the control group (81%) than in "giant" ESD group (68%) without reaching statistical significance (p: 0.2). Dissection time was significantly longer in the "giant" ESD group (251 vs 108 min; p <0.001), however, dissection speed was significantly higher (0.35 vs 0.17 cm2/min; p: 0.02).). Post-ESD stenosis was observed in 2 patients from the "giant" ESD group (8% vs 0% of control group, p: 0.03). No significant differences were found in delayed bleeding, perforation, local recurrences, and need for additional surgery.

Conclusions: ESD for superficial rectal tumors ≥ 8 cm is a feasible, safe, and effective therapeutic option.

Keywords: Adverse event; Curative resection; En bloc resection; Endoscopic submucosal dissection (ESD); Laterally spreading tumor (LST); Recurrence; Stenosis; Submucosal fibrosis.

MeSH terms

  • Colonoscopy
  • Colorectal Neoplasms* / pathology
  • Endoscopic Mucosal Resection* / adverse effects
  • Humans
  • Intestinal Mucosa / pathology
  • Intestinal Mucosa / surgery
  • Rectal Neoplasms* / pathology
  • Rectal Neoplasms* / surgery
  • Retrospective Studies
  • Treatment Outcome